Table 5.
HR | SE | 95% CI | Z value | P value | ||
---|---|---|---|---|---|---|
LL | UL | |||||
OS | ||||||
NLR | 1.319 | 0.986 | 0.305 | 5.711 | 0.370 | 0.711 |
dNLR | 0.615 | 0.718 | 0.063 | 6.052 | -0.420 | 0.677 |
PLR | 0.993 | 0.007 | 0.979 | 1.008 | -0.880 | 0.376 |
LMR | 1.125 | 0.330 | 0.633 | 1.998 | 0.400 | 0.689 |
SII | 1.000 | 0.002 | 0.996 | 1.004 | 0.040 | 0.967 |
Age | 1.098 | 0.037 | 1.028 | 1.172 | 2.780 | 0.005 |
T stage | 2.144 | 0.931 | 0.915 | 5.023 | 1.760 | 0.079 |
N stage | 2.238 | 0.967 | 0.960 | 5.217 | 1.860 | 0.062 |
M stage | 3.815 | 3.314 | 0.695 | 20.942 | 1.540 | 0.123 |
RFS | ||||||
NLR | 0.537 | 0.460 | 0.100 | 2.882 | -0.720 | 0.469 |
dNLR | 1.149 | 1.267 | 0.132 | 9.975 | 0.130 | 0.899 |
PLR | 1.004 | 0.004 | 0.995 | 1.012 | 0.890 | 0.375 |
LMR | 1.098 | 0.234 | 0.724 | 1.666 | 0.440 | 0.659 |
SII | 1.001 | 0.002 | 0.998 | 1.004 | 0.620 | 0.534 |
T stage | 1.804 | 0.595 | 0.946 | 3.442 | 1.790 | 0.073 |
N stage | 1.977 | 0.730 | 0.958 | 4.079 | 1.840 | 0.065 |
M stage | 2.458 | 2.021 | 0.490 | 12.321 | 1.090 | 0.274 |
NLR: neutrophil to lymphocyte ratio; dNLR: derived neutrophil to lymphocyte ratio; PLR: platelet to lymphocyte ratio; LMR: lymphocyte to monocyte ratio; SII: systemic immune-inflammation index; OS: overall survival; RFS: recurrence-free survival; HR: hazard ratio; SE: standard error; 95% CI: 95% confidence interval; LL: lower limit; UL: upper limit.